Avanir Pharmaceuticals Will Pay Over $108 Million to Resolve Illegal Kickback Allegations Involving Its Drug Nuedexta, Three Whistleblowers Will Share $17 Million Award

Avanir Pharmaceuticals Will Pay Over $108 Million to Resolve Illegal Kickback Allegations Involving Its Drug Nuedexta, Three Whistleblowers Will Share $17 Million Award

Back in 2017, CNN published an investigation entitled, “The little red pill being pushed on the elderly.” The red pill was Nuedexta, which is used to treat a rare condition: pseudobulbar affect, also known as PBA. Now, its maker, Avanir Pharmaceuticals, has agreed to pay $108 million to resolve allegations that it offered illegal kickbacks to physicians to boost sales of the drug. 

Two False Claims Act complaints initiated the case against Avanir. The whistleblowers behind them will share a reward surpassing $17 million.

According to prosecutors, the doctors bribed by Avanir routinely prescribed the drug to people who didn’t need it. Medicare and other government healthcare programs were then billed for these prescriptions. Drugs.com estimates the price of Nuedexta at approximately $1,235 for a supply of 60 capsules....

Featured Stories